NCT03731858

Brief Summary

ICSI has increased nowadays for treating cases of longstanding infertility . HbA1c has an important value in evaluating glucose level in blood

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 3, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 6, 2018

Completed
4 days until next milestone

Study Start

First participant enrolled

November 10, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2019

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2019

Completed
Last Updated

January 9, 2019

Status Verified

November 1, 2018

Enrollment Period

8 months

First QC Date

November 3, 2018

Last Update Submit

January 8, 2019

Conditions

Infertility

Outcome Measures

Primary Outcomes (1)

  • the number of ladies who will get pregnant

    the ladies who will become pregnant after ICSI

    within one year

Eligibility Criteria

Age20 Years - 42 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsinfertile ladies
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

-Any lady with infertilty and has a recurrent ICSI trials

You may qualify if:

  • females with infertility from 20 to 42 years old

You may not qualify if:

  • females with age below 20 or above 42 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Algazeerah and Kasralainy hospital

Giza, Egypt

RECRUITING

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Mahmoud Alalfy, PhD

    Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

    STUDY CHAIR

Central Study Contacts

Mahmoud Alalfy, PhD

CONTACT

01002611058mahmoudalalfy@ymail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 2018

First Posted

November 6, 2018

Study Start

November 10, 2018

Primary Completion

July 1, 2019

Study Completion

July 15, 2019

Last Updated

January 9, 2019

Record last verified: 2018-11

Locations

EG(1)